Prestige Wealth Management Group’s Zimmer Biomet ZBH Stock Holding History

Prestige Wealth Management Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.17K	Sell	57 -28	-33%	-$2.57K	﹤0.01%	550
2025 Q4	$7.67K	Sell	85 -18	-17%	-$1.71K	﹤0.01%	495
2025 Q3	$10.2K	Sell	103 -18	-15%	-$1.78K	﹤0.01%	455
2025 Q2	$11.1K	Hold	121	–	–	﹤0.01%	424
2025 Q1	$13.7K	Sell	121 -6	-5%	-$642	﹤0.01%	393
2024 Q4	$13.4K	Hold	127	–	–	﹤0.01%	415
2024 Q3	$13.7K	Sell	127 -3	-2%	-$327	﹤0.01%	401
2024 Q2	$14.1K	Sell	130 -4	-3%	-$472	﹤0.01%	361
2024 Q1	$17.7K	Sell	134 -22	-14%	-$2.75K	﹤0.01%	360
2023 Q4	$19K	Sell	156 -59	-27%	-$6.58K	﹤0.01%	347
2023 Q3	$24.1K	Hold	215	–	–	0.01%	313
2023 Q2	$31.3K	Hold	215	–	–	0.01%	311
2023 Q1	$27.8K	Sell	215 -3	-1%	-$377	0.01%	295
2022 Q4	$27.8K	Sell	218 -4	-2%	-$464	0.01%	312
2022 Q3	$23K	Buy	222 +48	+28%	+$5.27K	0.01%	299
2022 Q2	$18K	Buy	174 +66	+61%	+$7.83K	﹤0.01%	352
2022 Q1	$14K	Buy	108 +18	+20%	+$2.17K	﹤0.01%	410
2021 Q4	$12K	Sell	90 -6	-6%	-$785	﹤0.01%	459
2021 Q3	$14K	Hold	96	–	–	﹤0.01%	428
2021 Q2	$15K	Sell	96 -12	-11%	-$1.94K	﹤0.01%	403
2021 Q1	$17K	Hold	108	–	–	﹤0.01%	385
2020 Q4	$16K	Buy	108 +3	+3%	+$424	﹤0.01%	390
2020 Q3	$14K	Sell	105 -6	-5%	-$784	﹤0.01%	397
2020 Q2	$13K	Buy	111 +3	+3%	+$346	﹤0.01%	393
2020 Q1	$11K	Buy	108 +64	+145%	+$8.39K	﹤0.01%	375
2019 Q4	$6K	Sell	44 -2	-4%	-$276	﹤0.01%	416
2019 Q3	$6K	Buy	46 +10	+28%	+$1.29K	﹤0.01%	403
2019 Q2	$4K	Hold	36	–	–	﹤0.01%	426
2019 Q1	$4K	Sell	36 -133	-79%	-$15.1K	﹤0.01%	429
2018 Q4	$17K	Buy	+169	New	+$19K	0.01%	345

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prestige Wealth Management Group's ZBH Position: Q1 2026 in Review

Prestige Wealth Management Group reduced its Zimmer Biomet (ZBH) stake by 33% in Q1 2026, selling an estimated $2.57K and leaving 57 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Prestige Wealth Management Group first reported a position in ZBH in Q4 2018 and has held it in 30 quarters since. The position peaked at $31.3K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Prestige Wealth Management Group held 57 shares of Zimmer Biomet worth $5.17K as of Q1 2026.
Prestige Wealth Management Group sold 28 Zimmer Biomet shares in Q1 2026, an estimated $2.57K.
Zimmer Biomet made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q1 2026, its #550 holding.
Prestige Wealth Management Group first reported a position in Zimmer Biomet in Q4 2018 and has held it in 30 quarters since.
Prestige Wealth Management Group's Zimmer Biomet position peaked at $31.3K in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.